Stock & Company Details
Align Technology, Inc. $ALGN
Price:
N/A
N/A
72M
$10B
52 Week High:
N/A
10 Day Average Volume:
N/A
24.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALGN technical indicators
Latest Align Technology, Inc. (ALGN) indicator readings as of 2026-10-09.
ALGN's 14-day RSI is 39.5, in neutral territory. At $142.71 it is trading 16.0% below its 200-day moving average of $169.83, and below its 50-day average of $157.00. Price sits in the middle of its Bollinger Bands ($138.42 to $153.35). ADX reads 28.3, indicating a trending market.
ALGN backtested strategy results
How 4 rule-based strategies performed on Align Technology, Inc. (ALGN) over recent history, last backtested 2026-10-07. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | -72.9% | 19% | 16 | -82.2% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +65.3% | 37% | 19 | -32.3% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -36.0% | 21% | 34 | -51.5% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +1.5% | 61% | 31 | -53.6% |
Overview
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.
Finance Bot
Ask your questions
Start by typing a question below.
